Navigation Links
Intermittent Catheters - Olive Tip Coude

ProductsIntermittent Catheters - Olive Tip Coude
Company Coloplast
Item Intermittent Catheters - Olive Tip Coude
Features 
  • Round tip
  • Frosted surface
    Double lateral eyelets maximize drainage
  • Color-coded funnel
  • Latex-free
Description Intermittent catheter
Info Coloplast
Customer Service: (800) 533-0464
Web site: http://www.us.coloplast.com

Related medicine products :

1. SCD Sequential Compression System Intermittent Pneumatic Compression
2. Firlit-Sugar Intermittent Catheters
3. Intermittent Catheters - Long/Adolescent
4. Intermittent Catheters - Long/Adult
5. Intermittent Catheters - Female
6. Intermittent Catheters - Coude
7. Advance Plus Intermittent Catheter (Kit)
8. Acute Intermittent Porphyria Enzyme
9. EPT-DX Steerable Diagnostic Catheters
10. Pacel Bipolar Pacing Catheters
11. Dual Pressure Sensor Intravascular Mikro-Tip Pressure Catheters; SPC-721
...C. (CBI) Prolactin ELISA kit is used for the quant... plasma. Human prolactin (lactogenic hormone) is a... weight of approximately 23,000 daltons. The prola...ch ELISA method. The samples and diluted anti-prol...
...it is enzyme immunoassay kit for the quantitative ...on in serum. Enzyme immunoassay (EIA) permits the ... hormones in body fluids and provides an accurate,.... This enzyme immunoassay method makes it possible...
...d Immunosorbent Assay (ELISA) serves the quantitat...RBP) from plasma, serum and,urine. In a 1 hour inc...n,available excess of polyclonal rabbit antibodies...of the microtitre plates. After a washing step, to...
The AxSYM BNP assay allows you to measure more acute changes in the status of your heart due to a shorter half-life of BNP versus NT-ProBNP. The AxSYM BNP assay is fully automated, which means fast,
Medicine Products:
(Date:1/8/2009)... Pa., Jan. 8 Cephalon, ... Baldino, Jr., Ph.D., Chairman and CEO will prese... held on January 13, 2009 in San Francisco, CA at ...rn Time). The presentation will be webcast live on...ebsite. , , The webcast will be archived for o...
(Date:1/8/2009)...,s Email Encryption business continues to drive ov...e-FirstCall/ -- Zix Corporation (ZixCorp(R)), (Nas...mail encryption and e-prescribing, today offered a...Rick Spurr. , , "We ended the year on a high no...the highest orders for the year in the fourth quar...
(Date:1/8/2009)...netically-navigated guidewire provides minimally-i... , AUSTIN, Texas, Jan. 8 The He...he world to use the new Stereotaxis RF PowerAssert...nic total occlusions (CTOs), or complete blockages..., Austin Heart interventional cardiologist, Frank ...
(Date:1/8/2009)...PHIS, Tenn., Jan. 8 St. Jude Child... Group announced that FedExCup Runner-Up,Camilo V... St. Jude with a,pledge to match Singh,s donation...n the 2009 PGA TOUR. Eagles for St. Jude is a pow...Champion Vijay Singh and rising LPGA star Morgan,...
Breaking Medicine News(10 mins):Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 2Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 3Health News:Zix Corporation CEO Provides Corporate Update for Q4 and Year-End 2008 4Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...archers from Australia have recently shown, using ...es that valproate, a commonly used anti-convulsant...r, is an anti-androgen and anti-progestin. // Ant...h a high prevalence of reproductive dysfunction co...
...s Smith, a former psychiatric patient has been jai...ertson to death in October last year in a Glasgow'... year after being // released from a psychiatric h...rdered he be detained indefinitely for another vio...
... around a crowd, and you'll see that lots of middl...doing about this? Quite a bit, it turns out, repor...guys are walking // around with hundreds more hai...early test of what's been called hair cloning. An ...
...nant women consuming over eight cups of coffee a d...ding to a Danish study, fetal death was twice as l...nant // women who did not drink coffee. Adjusting...kened the association somewhat, but heavy coffee d...
Other Medicine News:Health News:Man Bludgeons Friend, Gets Life Term 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 2Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 3Health News:Scientists Seek New Ways To Grow Hair On Bald Pates 4Health News:Coffee In Pregnancy May Be Risky: Study 2
(Date:12/29/2008)... Md., Dec. 29 The winne...ch Protection was announced today by Dr. Peter G. ...mprovement Institute. , , The winner of the an...derson Cancer Center -- for its best practice " ...ram provides for 1) enhanced human subjects protec...
(Date:12/27/2008)...Boisselier breaks 5-year silence, offers to ease c...lic , , LAS VEGAS, Dec. 27 /PRNewswire-USNewswi...y Eve, the first cloned child, Dr. Brigitte Boisse...roject, said Eve and other babies cloned by her co... no one invading their families, privacy. , , "...
(Date:12/17/2008)...st, Most Complex of Its Kind; 80 Percent of Trauma... Dec. 17 A multi-disciplinary team...tly performed the first near-total face transplan...rocedure performed within the past two weeks, surg... suffered severe facial trauma -- essentially repl...
(Date:12/17/2008).... 17 Delcath Systems, I...ent of Pamela R. Contag, Ph.D., to Delcath,s Board...xecutive with extensive experience working with in...LOGO: http://www.newscom.com/cgi-bin/prnh/200811...balt Technologies, Inc. in 2006 and served as CEO....
Breaking Medicine Technology:2008 Human Research Protection Award Recipients Announced 2'We're Ready to Prove It!' 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 2Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant 3Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Onyx Pharmaceuticals to Present at Bank of America Health Care Conference 5236 1Stroke Survivors Walk Better With Human Help 18848 1Stroke Survivors Walk Better With Human Help 18848 2IRIDEX Announces First Quarter 2008 Conference Call and Release Date 18844 1Nations First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U S 18840 1Nations First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U S 18840 2Nations First of its Kind Consumer Medication Return Initiative Creates Momentum for Safe Drug Disposal in the U S 18840 3
...ertuzumab shows promising results in,advanced brea...evelopment initiated, BASEL, Switzerland, June 4, ...the exciting new cancer medicine pertuzumab, a HER...our activity in,patients with pre-treated HER2 pos... The study showed that one in five patients,respon...
...rate Significant Survival Benefit in,Liver Cancer ...- Bayer,HealthCare Pharmaceuticals Inc. and Onyx P...R) (sorafenib) tablets significantly,extended over...noma,(HCC), or primary liver cancer versus those t...sults were presented at the 43rd,annual meeting of...
Other Medicine Technology:Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7